Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass E, Marsh M, Mangione C, Bressler N, et al. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass E, Marsh M, Mangione C, Bressler N, et al
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • An estimated 2,907,691 Americans age 40 and older have vision impairment.  
  • Estimated Specific Prevalence Rates for Visual Impairment and Blindness  
  • An estimated 51,593 Americans ages 40-49 are blind. That grows to 86,623 at ages 75-79 and just under 1 million for ages 80+.  
  • From 2005 – 2008, around 4.2 million diabetics age 40 and older had diabetic retinopathy.  Of these, 655,000 had advanced diabetic retinopathy that could lead to severe vision loss.  
  • Various studies found between 13% and 24% of age-related macular degeneration (AMD) patients had experienced visual hallucinations.